Contrasting Summit Healthcare Acquisition (SMIH) and Its Peers

Summit Healthcare Acquisition (NASDAQ:SMIHGet Rating) is one of 712 publicly-traded companies in the “Holding & other investment offices” industry, but how does it contrast to its competitors? We will compare Summit Healthcare Acquisition to related companies based on the strength of its profitability, dividends, institutional ownership, earnings, analyst recommendations, risk and valuation.

Profitability

This table compares Summit Healthcare Acquisition and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Summit Healthcare Acquisition N/A 46.53% 8.78%
Summit Healthcare Acquisition Competitors 11.67% -68.35% 2.51%

Valuation and Earnings

This table compares Summit Healthcare Acquisition and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Summit Healthcare Acquisition N/A -$550,000.00 12.46
Summit Healthcare Acquisition Competitors $1.63 billion $82.64 million 28.72

Summit Healthcare Acquisition’s competitors have higher revenue and earnings than Summit Healthcare Acquisition. Summit Healthcare Acquisition is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings and target prices for Summit Healthcare Acquisition and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Summit Healthcare Acquisition 0 0 0 0 N/A
Summit Healthcare Acquisition Competitors 113 595 910 18 2.51

As a group, “Holding & other investment offices” companies have a potential upside of 63.07%. Given Summit Healthcare Acquisition’s competitors higher probable upside, analysts plainly believe Summit Healthcare Acquisition has less favorable growth aspects than its competitors.

Institutional and Insider Ownership

63.4% of shares of all “Holding & other investment offices” companies are held by institutional investors. 18.6% of shares of all “Holding & other investment offices” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Risk and Volatility

Summit Healthcare Acquisition has a beta of 0.01, meaning that its stock price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition’s competitors have a beta of 0.06, meaning that their average stock price is 94% less volatile than the S&P 500.

Summary

Summit Healthcare Acquisition competitors beat Summit Healthcare Acquisition on 8 of the 10 factors compared.

About Summit Healthcare Acquisition

(Get Rating)

Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.

Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.